Explainable Machine Learning to Identify Clinical, Environmental, and Social Factors Associated with Diagnosed Pediatric Asthma.

Authors

Khamron Micheals, Wilson Nguyen, Yaseen Alwesabi

Published in

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. Oct 05, 2026. Epub Oct 05, 2026.

Abstract

Pediatric asthma reflects clinical, physiologic, environmental, and social determinants, yet most classification models use clinical variables alone and are difficult to interpret.
To use explainable machine learning on nationally representative data to identify and rank factors associated with a reported physician diagnosis of asthma in U.S. children, and to test whether fewer higher-ranked features retain full performance.
We analyzed 6,567 children aged 6 to 17 years in NHANES 2007-2012 (weighted asthma prevalence 18.8%). Of 477 harmonized variables, 22 entered the primary CatBoost model after pre-specified eligibility screening, feature engineering, and correlation pruning. Data were split into training, validation, and held-out internal test sets (60/20/20), with the operating threshold locked on validation. SHAP ranked features; 95% confidence intervals used stratified bootstrap.
The primary model reached a test-set AUC of 0.78 (95% CI 0.74-0.81), sensitivity 0.75, specificity 0.63, and negative predictive value 0.92. The highest-ranked features included recent wheezing, family history of asthma, general health status, serum cotinine, household size, FEV₁/FVC ratio, race/Hispanic origin, insurance coverage, and U.S. birth. A reduced model of these ten plus two spirometry-availability indicators had more favorable point estimates on every metric (AUC 0.80; paired difference 0.023, 95% CI 0.007-0.041; sensitivity 0.79; specificity 0.67; negative predictive value 0.93).
Explainable machine learning recovers established clinical signals and ranks social and contextual factors associated with a reported pediatric asthma diagnosis; a parsimonious feature set retains this performance. Given the cross-sectional design and internal evaluation, external and prospective validation is required before clinical use.

PMID:
42833373
Bibliographic data and abstract were imported from PubMed on 06 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.